124 related articles for article (PubMed ID: 37215360)
1. Between Regional Recommendations and National Implementation: An Analysis of the East African Community Partner States' Legislative Responses to TRIPS Obligations.
Olatunji OA
IIC Int Rev Ind Prop Copyr Law; 2023; 54(5):673-709. PubMed ID: 37215360
[TBL] [Abstract][Full Text] [Related]
2. The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan-from project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases.
Affara M; Lagu HI; Achol E; Karamagi R; Omari N; Ochido G; Kezakarayagwa E; Kabatesi F; Nkeshimana A; Roba A; Ndia MN; Abudo MU; Kabanda A; Mpabuka E; Mwikarago EI; Kutjok PE; Samson DD; Deng LL; Moremi N; Kelly ME; Mkama PBM; Magesa A; Balinandi SK; Pimundu G; Nabadda SN; Puradiredja DI; Hinzmann J; Duraffour S; Gabriel M; Ruge G; Loag W; Ayiko R; Sonoiya SS; May J; Katende MJ; Gehre F
BMC Med; 2021 Jul; 19(1):160. PubMed ID: 34238298
[TBL] [Abstract][Full Text] [Related]
3. National medicines regulatory authorities financial sustainability in the East African Community.
Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
[TBL] [Abstract][Full Text] [Related]
4. Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.
't Hoen EFM; Kujinga T; Boulet P
J Pharm Policy Pract; 2018; 11():31. PubMed ID: 30524732
[TBL] [Abstract][Full Text] [Related]
5. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
[TBL] [Abstract][Full Text] [Related]
6. Effects of scaling up various community-level interventions on child mortality in Burundi, Kenya, Rwanda, Uganda and Tanzania: a modeling study.
Hategeka C; Tuyisenge G; Bayingana C; Tuyisenge L
Glob Health Res Policy; 2019; 4():1. PubMed ID: 31168481
[TBL] [Abstract][Full Text] [Related]
7. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda.
Baldeh AO; Millard C; Pollock AM; Brhlikova P
J Pharm Policy Pract; 2023 Jan; 16(1):18. PubMed ID: 36717871
[TBL] [Abstract][Full Text] [Related]
8. TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?
Kerry VB; Lee K
Global Health; 2007 May; 3():3. PubMed ID: 17524147
[TBL] [Abstract][Full Text] [Related]
9. The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.
Motari M; Nikiema JB; Kasilo OMJ; Kniazkov S; Loua A; Sougou A; Tumusiime P
BMC Public Health; 2021 Mar; 21(1):490. PubMed ID: 33706726
[TBL] [Abstract][Full Text] [Related]
10. What is the impact of intellectual property rules on access to medicines? A systematic review.
Tenni B; Moir HVJ; Townsend B; Kilic B; Farrell AM; Keegel T; Gleeson D
Global Health; 2022 Apr; 18(1):40. PubMed ID: 35428250
[TBL] [Abstract][Full Text] [Related]
11. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Adekola TA
Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
[TBL] [Abstract][Full Text] [Related]
12. The East African Community mobile laboratory network prepares for monkeypox outbreaks.
Gehre F; Lagu HI; Achol E; Omari N; Ochido G; Shand K; Alvarado AM; Ruge G; Kezakarayagwa E; Kabatesi F; Ihorimbere T; Nkeshimana A; Roba A; Ndia MN; Githii SM; Kiiru JN; Samson DD; Nykwec GA; Moun IGC; Deng LL; Kelly ME; Mkama PBM; Msigwa FL; Magesa A; Pimundu G; Muyigi T; Nabadda SN; Nzeyimana E; May J; Affara M
J Public Health Afr; 2023 Jun; 14(6):2309. PubMed ID: 37680705
[TBL] [Abstract][Full Text] [Related]
13. Beyond the Numbers: Interpreting WHO's
Sabiiti W;
East Afr Health Res J; 2017; 1(1):2-7. PubMed ID: 34308153
[TBL] [Abstract][Full Text] [Related]
14. Fighting non-communicable diseases in East Africa: assessing progress and identifying the next steps.
Kraef C; Juma PA; Mucumbitsi J; Ramaiya K; Ndikumwenayo F; Kallestrup P; Yonga G
BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33184064
[TBL] [Abstract][Full Text] [Related]
15. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
Cohen-Kohler JC; Forman L; Lipkus N
Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
[TBL] [Abstract][Full Text] [Related]
16. The make or buy debate: considering the limitations of domestic production in Tanzania.
Wilson KR; Kohler JC; Ovtcharenko N
Global Health; 2012 Jun; 8():20. PubMed ID: 22747578
[TBL] [Abstract][Full Text] [Related]
17. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
[TBL] [Abstract][Full Text] [Related]
18. Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States.
Son KB; Lopert R; Gleeson D; Lee TJ
Global Health; 2018 Oct; 14(1):101. PubMed ID: 30355313
[TBL] [Abstract][Full Text] [Related]
19. Regulation of medical diagnostics and medical devices in the East African community partner states.
Rugera SP; McNerney R; Poon AK; Akimana G; Mariki RF; Kajumbula H; Kamau E; Mpawenimana S; Said SY; Toroitich A; Ronoh W; Sollis KA; Sonoiya S; Peeling RW
BMC Health Serv Res; 2014 Oct; 14():524. PubMed ID: 25366990
[TBL] [Abstract][Full Text] [Related]
20. The role of government agencies and other actors in influencing access to medicines in three East African countries.
Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
